Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

Understanding drug effects and careful monitoring are crucial for safe and effective dermatology treatments.

Use corticosteroid cream and triamcinolone injections for treating alopecia areata, and consider wigs and tranquilizers for support.

Stem cell treatments show promise for hair loss but need more research.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Smoking may worsen hair loss, but more research is needed.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Surgical robots have improved but still can't perform tasks or make decisions on their own.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Turning white fat into brown-like fat could help fight obesity and type 2 diabetes.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

Platelet-rich plasma shows promise for skin and hair treatments but needs more research and standardization.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Cannabinoids may help treat various skin conditions.

Hair follicles may soon be used more for targeted and systemic drug delivery.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Nanoparticles can improve skin drug delivery but have challenges like toxicity and stability that need more research.

Particles around 100 nm can penetrate and stay in hair follicles without passing through healthy skin, making them safe for use in topical products and useful for targeted drug delivery.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Dutasteride, fesoterodine, and finasteride are beneficial for older patients, while most other drugs should be used cautiously or avoided.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Smoking may contribute to hair loss in men.